A new pharmacophore-based modeling procedure, including homology modeling, pharmacophore study, flexible molecular docking, and long-time molecular dynamics (MD) simulations, was employed to construct the structure of the human 5-HT 2C receptor and determine the characteristics of binding modes of 5-HT 2C receptor agonists. An agonist-receptor complex has been constructed based on homology modeling and a pharmacophore hypothesis model based on some high active compounds. Then MD simulations of the ligand-receptor complex in an explicit membrane environment were carried out. The conformation of the 5-HT 2C receptor during MD simulation was explored, and the stable binding modes of the studied agonist were determined. Flexible molecular docking of several structurally diverse agonists of the human 5-HT 2C receptor was carried out, and the general binding modes of these agonists were investigated. According to the models presented in this work and the results of Flexi-Dock, the involvement of the amino acid residues Asp134, Ser138, Asn210, Asn331, Tyr358, Ile131, Ser132, Val135, Thr139, Ile189, Val202, Val208, Leu209, Phe214, Val215, Gly218, Ser219, Phe223, Trp324, Phe327, and Phe328 in agonist recognition was studied. The obtained binding modes of the human 5-HT 2C receptor agonists have good agreement with the site-directed mutagenesis data and other studies. DOI: 10.1111DOI: 10. /j.1745DOI: 10. -7270.2007.00295.x 5-Hydroxytryptamine (5-HT; serotonin) is a major neurotransmitter that is thought to be involved in many central nervous system processes including feeding, anxiety, aggression, sexual behavior, mood and pain [1− 3]. 5-HT exerts its physiological effects by an action on a diverse family of cell surface receptor proteins. The 5-HT 2C receptor is one of the serotonin receptors belonging to a large group of seven transmembrane (TM)-spanning G protein-coupled receptors (GPCRs). Direct and indirect evidence from clinical studies suggest that 5-HT 2C receptor agonists can effectively resist obesity without inducing any tolerance [4−7]. Although approximately half of all marketed drug targets are GPCRs [8], there are no selective 5-HT 2C receptor agonists developed and marketed for the treatment of obesity [4] . Because of the huge market in this area, tremendous interest has been attracted to research and development of anti-obesity drugs.
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Generally, the structure of the human 5-HT 2C receptor could be used as a starting point for the receptor structure-based design of new agonists. However, like other GPCRs belonging to the rhodopsin family, the 3-D struc-ture of the receptor is not easily amenable to determination by either X-ray crystallography or nuclear magnetic resonance spectroscopy. Therefore, the 3-D structure of bovine rhodopsin [9, 10] serves as a template to construct 3-D models for other GPCRs [11] . But the low sequence similarity among GPCRs makes the homology modeling imperfect or questionable.
In this study, an integrated strategy, including homology modeling, pharmacophore study, long-time molecular dynamics (MD) simulations in an explicit membrane environment, and Flexi-Dock, was employed for constructing a reliable 3-D model of the 5-HT 2C receptor, and determining the features of the binding modes of 5-HT 2C receptor agonists. Under the guidance of a pharmacophore derived from published agonists, a complex of the receptor with an agonist was established based on a 3-D model of the 5-HT 2C receptor from homology modeling. Then long-time MD simulation was carried out on the complex that was placed in a phospholipid bilayer and solvated in solvent water, to find the most probable structure of the complex. Finally, a series of agonists were docked into the final structure of the 5-HT 2C receptor to explore the binding mode between the 5-HT 2C receptor and its agonist. The obtained binding mode is in good agreement with the site-directed mutagenesis data and other studies. Therefore, this binding mode should be helpful in determining the roles of the key residues involved in agonist binding, and useful in discovering potential agonists for the 5-HT 2C receptor.
Materials and Methods

Molecular modeling of 5-HT 2C receptor
Modeling of the α-helix bundle, extracellular and intracellular regions were carried out sequentially.
The sequence of the 458 amino acids of the human 5-HT 2C receptor was taken from the Swiss-Prot Database (entry P28335; http://us.expasy.org/sprot/). The crystal structure of bovine rhodopsin at 2.80 Å resolution (PDB entry 1F88) [9] from the Protein Data Bank [12] was used as a template, the Homology module of InsightII (version 2000; Molecular Simulation Inc., San Diego, USA) and the ClustalW algorithm [13] were applied in sequence alignment, and the Blosum scoring matrix [14] was employed to obtain the best-fit alignment. The best alignment was selected according to not only the value of the alignment score, but also the reciprocal positions of conserved residues.
The sequence alignment results carried out by the ClustalW algorithm [13] are depicted in Fig. 1 . The sequence identity between rhodopsin and the 5-HT 2C Fig. 1 Sequence alignment of 5-HT 2C (HT2C) with rhodopsin (RHOD; 1F88) generated by the ClustalW algorithm
In the sequences, an asterisk (*) indicates an identical or conserved residue, a colon (:) indicates a conserved substitution, a stop (.) indicates a semi-conserved substitution. EL, extracellular loop; TM, transmembrane.
receptor is 20.5% except at the N-terminus and Cterminus. The conserved disulfide bond between residues Cys127 at the beginning of TM3 and Cys207 in the middle of extracellular loop 2 was also created and kept as a constraint in the geometric optimization. The N-terminus, C-terminus and intracellular loop CL-III were not modeled as they are not directly involved in the binding of agonists, and poor sequence conservation exists in this region within the GPCR family [15] .
The resultant structure of the 5-HT 2C receptor was optimized using molecular mechanics methods with the following parameters: a distance-dependent dielectric constant of 1.0; non-bonded cutoff 8 Å, Amber force field [16] and Kollman all-atom charges; and conjugate gradient minimization until 0.05 kcal/(mol·Å). The minimized structure was validated using PROCHECK [17] .
3-D pharmacophore study
A common set of distances among the hypothetical pharmacophoric points was constructed by the DISCO module of SYBYL 7.1 (Tripos Association, St. Louis, USA). The initial structures of these compounds were built and energetically minimized using the Tripos force field with Gasteiger-Hückel charges [18] . The classical procedure of DISCO was followed: (1) combining conformer databases to create a molecular spreadsheet; (2) assigning features to the rows automatically; (3) moving features to the conformers; (4) scanning the reference compound 6; (5) admitting between three and seven points of feature requirements; (6) computing the model; and (7) examining and analyzing the results spreadsheet.
MD simulation
Nowadays, the commonly accepted method of carrying out MD simulations of membrane proteins is the use of the phospholipid bilayer solvated by water, to provide the optimum environment [19−22] .
A pre-equilibrated 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) bilayer with 128 lipid molecules was obtained from Dr. TIELEMAN (http://moose.bio.ucalgary. ca/; University of Calgary, Calgary, Canada), then the GROMACS 3.1.4 package [23] and an in-house program were used to generate and equilibrate the POPC bilayer with 272 lipid molecules. The protein was embedded in the pre-equilibrated POPC lipid bilayer using similar procedures to those used in our previous work [22] . A cylindrical hole was made in the center of the bilayer by removing lipids whose P atoms fell within 2.0 Å of the 5-HT 2C receptor. A short MD simulation with a radially acting repulsive force was used to drive any remaining atoms out of the cylinder and into the bilayer. As shown in Fig.  2 , the protein was oriented with the main axis along the Zaxis. In the 5-HT 2C receptor, Arg and Lys concentrate at the cytoplasmic boundary of membrane proteins, where they interact with the lipid at the level of the phospholipids headgroups [24] . In our model, the positively charged side chains of the Arg and Lys residues in the 5-HT 2C receptor are positioned at the level of the phospholipid headgroups. Thus, the TM helical domains reside in a complex environment consisting of three distinct phases: a hydrophobic core of the membrane defined by the phospholipids chains; a mixed hydrophobic-hydrophilic region comprised of the phospholipids headgroups; and the aqueous cytoplasm. Before starting MD simulations, the pKa was calculated to determine if any of the residues in the receptors were likely to adopt non-standard ionization states. The surfaceaccessibility-modified Tanford-Kirkwood method of Matthew [25, 26] encoded in MacroDox version 3.2.2 [27] was employed to determine the protonation status of each titratable residue in the receptor at body pH value. The MD on 5-HT 2C -agonist complex in a POPC/water environment was carried out with the parallel version of the MD program GROMACS 3.1.4 [23] , using constant number of particles, pressure and temperature (NPT) and periodic boundary conditions. The LINCS method [28] was used to constrain bond lengths, allowing an integration step of 2 fs. Electrostatic interactions were calculated with the particle mesh Ewald algorithm [29, 30] . A constant pressure of 1 bar was applied independently in X, Y and Z directions of the whole system with a coupling constant of 1.0 ps. Water, lipids and protein were coupled separately to a temperature bath at 300 K with a coupling time of 0.1 ps using a Berendsen thermostat [31] . The values of the semi-isothermal compressibility were set to 4.5×10 −5 bar −1 for water simulations. The molecular topology for agonist 6 was generated by PRODRG (http://davapc1. bioch.dundee.ac.uk/programs/prodrg/prodrg.html) [32] . The atomic charges of agonist 6 were assigned using the CHELPG procedure at the Hartree-Fock level with a 6-311G* basis set [33] . MD simulations were carried out using the software package GROMACS 3.1.4 [23] . The GROMACS force field was applied for protein and the lipid parameters adopted were those used in previous MD studies of lipid bilayers [22, 34] .
Molecular docking
To further validate the 3-D model of the activated conformation of the 5-HT 2C receptor, all agonists in Table 1 were docked into the binding pocket after MD simulation. As the ligands might interact with the receptor in different and diverse ways, even among homologous ligands acting 
Results and Discussion
Homology modeling
The molecular mechanism by which agonists bind to the human 5-HT 2C receptor remains a central unresolved problem for biochemists and pharmacologists, because of the absence of clear structural data. For this reason, the homology modeling of the human 5-HT 2C receptor was carried out using bovine rhodopsin as the template [9] . In order to describe the structure clearly, the TM segments from all seven subunits were designed as TM1, TM2, TM3, TM4, TM5, TM6, and TM7. It is well known that all rhodopsin-like receptors consist of seven TM α-helices with the same arrangement connected by hydrophilic loops. So the hydrophobic α-helices of the 5-HT 2C receptor were constructed by homology modeling based on the crystal structure of rhodopsin. As some fragments of the intracellular loops of the rhodopsin are missing in the crystal structure, the configuration of the hydrophilic loops of the 5-HT 2C receptor was determined using the LOOP-SEARCH utility in the Homology module of InsightII [22] , taking into account both the root mean square values of the top 10 candidates from the default loop database and geometrical compatibility with other parts of the receptor.
In the procedure of modeling the hydrophilic loops, a key point is the formation of the highly conserved disulfide bond between the Cys127 at the beginning of TM3 and the Cys207 in extracellular loop 2. The modeled 3-D structure of the 5-HT 2C receptor is shown in Fig. 3 .
The Ramachandran plot by PROCHECK [17] analysis indicated that approximately 94% of residues in the 5-HT 2C receptor model are in either the most favored or in the additionally allowed regions, suggesting that the constructed 3-D model of the 5-HT 2C receptor should be reliable and could be used for further studies.
Pharmacophore hypothesis and binding pocket
The template (bovine rhodopsin) used in the homology modeling was crystallized with a ground conformation different from that of the active state [9] . It is suitable for the binding of antagonists, but not accurate enough for retrieving known agonists [37] . Therefore, the model of the 5-HT 2C receptor based on this crystal structure would be the inactive form rather than the agonist bound form.
To build a topographical model of the agonist binding conformation, 18 agonists of the 5-HT 2C receptor from published reports [38] with high activities and common chemical features were used to generate an agonist-based pharmacophore model (Table 1 ) by the DISCO module of SYBYL 7.1. Four hypothetical pharmacophore elements, including three aromatic points and one hydrogen bond point, were obtained, as shown in Fig. 4(A) (annotated  with a, b, c and d ). This pharmacophore model was used to calibrate the 3-D structure of the constructed structure of the 5-HT 2C receptor.
The possible binding site of the receptor for the agonist was identified on the extracellular side of the TM domain and partly covered by the second extracellular loop, through docking of the pharmacophoric elements and taking into account some published data about the position of the agonist binding site [37,39−48] . The cavity is mainly com- posed of the conserved residues of Asp134, Phe223, Trp324, Phe327, Phe328, Val354, and Tyr358 on the helix TM3, TM5, TM6 and TM7. The site can be divided into two parts with different properties: the area near helix of TM3 and TM7 that is hydrophilic; and the other near TM5 and TM6 that is hydrophobic. In the binding pocket, the agonists interact with these areas by hydrogen-bonding and hydrophobic interactions, respectively. To give a clear representation of these interactions, a schematic picture is given in Fig. 4(B) .
MD simulation
With the identified binding site, the most active agonist (compound 6; Table 1 ) was manually docked into the receptor. In the binding pocket, the aromatic end of agonist 6 was put into the hydrophobic cave, and the head of the agonist with a nitrogen points to the hydrophilic cave. During this process, some residues of the 5-HT 2C receptor, especially the angles of the side chains of the residues lining the binding pocket, were modified manually to avoid unacceptably steric contacts with the ligand. This is understandable as the conformation of the preliminary 5-HT 2C receptor model was constructed based on the crystal structure of rhodopsin with an inactive form. This initial structure was then subjected to geometrical optimization and simulation by the MD method.
To generate a correct model of an activated state, the complex of the 5-HT 2C receptor and compound 6 was minimized using molecular mechanics followed by longtime MD simulation in the real phospholipid bilayer/water environment. As shown in Fig. 2 , the complex was placed into the water-solvated phospholipid bilayer. Single-point charged (SPC) was used as a water model [31] , which has been shown to behave well in lipid bilayer/water simulations [49, 50] . In order to provide a neutral simulation system, 7 Cl − ions replaced water molecules at the positions of low Coulomb potential in 5-HT 2C /agonist/ POPC/water systems. Lastly, the MD simulation system contains 241 POPC lipids, 8007 water molecules, and 7 Cl − , giving a total of 39,317 atoms in a box of dimensions 8.8×8.8×7.7 nm
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. The whole MD simulation system was set up as described above.
The potential energy of the whole system and heavy atom root mean square deviation (RMSD) from the starting structure are important criteria for the convergence of the free MD simulations. As is shown in Fig. 5 , the potential energy of the whole system under study became stable at approximately −6.365×10
5 KJ/mol after approximately 2.0 ns of the MD simulation, and the RMSD with respect to the starting structure reached stability, with an RMSD value of 0.25 nm, also after approximately 2.0 ns. These results suggested that a relatively stable conformation of In order to clearly compare the binding mode with the pharmacophore hypothesis, the four pharmacophore elements, including three aromatic elements (A, B and C) and one hydrogen-bonding element (D), with agonist 6 and some key residues within the distance of 5 Å of the agonist were depicted (Fig. 6) , which were extracted from last snapshot of the MD simulation. It can be seen from Fig. 6 , after the long-time MD simulation, the hydrogenbonding element (D) was positioned to the residues of Asp134 and Tyr358, and the aromatic elements (A, B and C) point to hydrophobic parts near TM5 and TM6. The characteristic of the interaction between the agonist and the 5-HT 2C receptor agrees well with our pharmacophore hypothesis established by the above DISCO study. A comparison between the model after MD simulation, which was built based on the pharmacophore hypothesis, and the model from conventional homology modeling was also made. We found that the binding site of pharmacore-directed modeling was larger than the conventional one and the conformation of some residues was different.
Molecular docking
To further explore the common characteristics of agonist binding, all the agonists listed above were flexi-docked into the binding pocket of the 5-HT 2C receptor with the active conformation after MD simulation. Geometrical optimization with molecular mechanics was carried out for the docked complexes. Then the interaction between the docked agonists and the 5-HT 2C receptor in each complex was studied by LIGPLOT [51] . The 2-D representatives of the interaction models of all complexes were studied by LIGPLOT. Four representative pictures of the 2-D interaction models are shown in Fig. 7 . We found that: agonist 2 and 9 might have hydrogen-bond interactions with the residue of Ser138; agonist 7 interacted with Asp134 by hydrogen bond; agonist 11 might interact with Asn210, Asn331 and Tyr358; and the rest of the agonists might have hydrogen-bond interactions with the residue of Tyr358. The obtained results of the molecular docking suggested that five amino acid residues of the receptor, that is, Asp134, Ser138, Asn210, Asn331, and Tyr358, might be hydrogen-bonded with the agonists. The residue of Tyr358 is the most popular because it provides an important hydrogen-bond interaction to the agonists. The amino acid residues of Ile131, Ser132, Val135, Thr139, Ile189, Val202, Val208, Leu209, Phe214, Val215, Gly218, Ser219, Phe223, Trp324, Phe327, and Phe328 form a suitable hydrophobic pocket between TM3, TM5, TM6, and TM7 to host the hydrophobic moiety of the agonists.
The experiments of Choudhary et al. [48] found that the mutation of phenylalanines to leucine in TM6 impact markedly on the binding of ligands. The involvement of the highly conserved aspartic acids of TM3 in the binding Vol. 39 The distance between the donor and acceptor of less than 3.4 Å is considered as a hydrogen bond, and a 4.1 Å distance between two hydrophobic atoms is considered to be a hydrophobic interaction. Illustrations generated by the LIGPLOT program [51] .
of some ligands was shown by Wang et al. [47] using an aspartic acid to asparagines mutant. The work of Roth et al. [44] has shown that mutation of the completely conserved tyrosine in TM7 had significant effects on the binding of some ligands to the 5-HT 2A receptor. As depicted in the homology modeling study by Bissantz et al. [37] , the agonist binding pockets of different D3 receptors and β2 receptors are mainly composed of aspartic acid in TM3, two residues of phenylalanine in TM6, and some residues of serine in TM5. Our binding modes established by ligandbased homology modeling and MD simulations were found to be in close agreement with the results from these studies.
Conclusions
Although the availability of high-resolution structural information for GPCRs has opened new vistas for molecular modeling of membrane proteins, homology modeling can not give a perfect structure alone for agonist binding because the conformation of the template is an inactive one. Therefore, other methods are needed to explore the binding mode of 5-HT 2C receptor agonists.
The molecular modeling and MD simulations presented in this work provide the first detailed study of the human 5-HT 2C receptor structure inserted into the phospholipid bilayer. A molecular model of the human 5-HT 2C receptor was created by homology modeling in this work. A reasonable and valuable pharmacophore hypothesis model was constructed based on some high active agonists by DISCO. MD simulations of the complex of the 5-HT 2C receptor with an agonist in an explicit membrane environment were carried out. The flexible molecular docking of the agonists of the 5-HT 2C receptor was carried out. The results of MD simulations and molecular docking allowed us to explore the binding mode of these agonists and to determine the amino acid residues involved in the recognition of 5-HT 2C receptor agonists. The amino acid residues of Asp134, Ser138, Asn210, Asn331, and Tyr358 are mainly in TM3 and TM7 hydrogen-bonded with agonists. Some aromatic residues and hydrophobic residues of Ile131, Ser132, Val135, Thr139, Ile189, Val202, Val208, Leu209, Phe214, Val215, Gly218, Ser219, Phe223, Trp324, Phe327, and Phe328 are involved in ligand recognition by the means of hydrophobic interaction or π-π interaction. The obtained binding modes of the 5-HT 2C receptor agonists are in agreement with studies by others [37, 44, 47, 48] .
